167 related articles for article (PubMed ID: 29667555)
1. Synthesis, Cytotoxicity and Antioxidant Activity of New Analogs of RC-121 Synthetic Derivatives of Somatostatin.
Naydenova E; Wesselinova D; Staykova S; Goshev I; Vezenkov L
Anticancer Agents Med Chem; 2018; 18(10):1417-1424. PubMed ID: 29667555
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro study of the anticancer activity of new analogs of octreotide.
Staykova S; Naydenova E; Wesselinova D; Kalistratova A; Vezenkov L
Protein Pept Lett; 2012 Dec; 19(12):1257-62. PubMed ID: 22670668
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antitumor activity of new octapeptide analogs of somatostatin containing unnatural amino acids.
Staykova STs; Wesselinova DW; Vezenkov LT; Naydenova ED
Amino Acids; 2015 May; 47(5):1007-13. PubMed ID: 25655387
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of receptors for somatostatin in various tumors using different analogs.
Srkalovic G; Cai RZ; Schally AV
J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids.
Naydenova E; Wesselinova D; Staykova S; Danalev D; Dzimbova T
Amino Acids; 2019 Sep; 51(9):1247-1257. PubMed ID: 31350614
[TBL] [Abstract][Full Text] [Related]
6. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
Nagy A; Schally AV; Halmos G; Armatis P; Cai RZ; Csernus V; Kovács M; Koppán M; Szepesházi K; Kahán Z
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1794-9. PubMed ID: 9465096
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ
J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
[TBL] [Abstract][Full Text] [Related]
9. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Schally AV; Redding TW
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490
[TBL] [Abstract][Full Text] [Related]
12. Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.
Capello A; Krenning EP; Breeman WA; Bernard BF; Konijnenberg MW; de Jong M
Cancer Biother Radiopharm; 2003 Oct; 18(5):761-8. PubMed ID: 14629824
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
Liebow C; Reilly C; Serrano M; Schally AV
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2003-7. PubMed ID: 2564678
[TBL] [Abstract][Full Text] [Related]
14. Effect of somatostatin analogs on gastric acid secretion in dogs and rats.
Schally AV; Colaluca J; Paulson D; Carter WH; Neitzschman HR; Lafaye H; Cai RZ
Int J Pept Protein Res; 1990 Sep; 36(3):267-74. PubMed ID: 1980670
[TBL] [Abstract][Full Text] [Related]
15. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro biological activity, hydrolytic stability and docking of new analogs of BIM-23052 containing halogenated amino acids.
Danalev D; Borisova D; Yaneva S; Georgieva M; Balacheva A; Dzimbova T; Iliev I; Pajpanova T; Zaharieva Z; Givechev I; Naydenova E
Amino Acids; 2020 Dec; 52(11-12):1581-1592. PubMed ID: 33215308
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity.
Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I
Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057
[TBL] [Abstract][Full Text] [Related]
18. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
Karashima T; Cai RZ; Schally AV
Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]